{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"63.7","upperLimit":"112.9","value":"73.6"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"31"}],"units":"Participants"}],"description":"Duration of overall survival (median) (months)","dispersionType":"80% Confidence Interval","groups":[{"description":"Patients receive paclitaxel IV over 3 hours on day 1. Treatment continues every 21 days in the absence of disease progression or unacceptable toxicity.\n\nPaclitaxel: Given IV","id":"OG000","title":"Treatment (Paclitaxel)"}],"paramType":"MEDIAN","reportingStatus":"POSTED","timeFrame":"The observed length of life from entry into the study to death or the date of last contact","title":"Overall Survival","type":"SECONDARY","unitOfMeasure":"Months"}